Vincent Panikurlangara v. Union of India

Vincent Panikurlangara v. Union of India, AIR 1987 SC 990, is a landmark judgment of the Supreme Court of India dealing with public health, drug regulation, and the scope of the right to life under Article 21 of the Constitution. The case arose through a Public Interest Litigation (PIL) filed to highlight the continued circulation of harmful drugs in India and the inadequate control exercised by authorities over the pharmaceutical sector.

The judgment is significant for recognising the State’s duty in a welfare system to ensure access to safe medicines, regulate drug standards, and protect citizens from injurious substances. At the same time, the Court maintained judicial restraint by refraining from interfering in technical policy decisions such as banning specific drugs or restructuring the pharmaceutical industry.

Facts of Vincent Panikurlangara v. Union of India Case

The petitioner, Vincent Panikurlangara, approached the Supreme Court by filing a Public Interest Litigation raising serious concerns regarding the pharmaceutical industry in India.

One of the central issues raised in the petition was the dominance of multinational pharmaceutical corporations in the Indian market. These corporations, originating from countries such as the United States, United Kingdom, Germany, Sweden, Japan and France, were stated to possess vast financial resources and generate substantial profits. It was contended that the Indian government exercised limited control over these corporations, which allowed them to operate in a manner that could adversely affect public health.

The petitioner relied upon the Hathi Committee Report of 1974, which had been commissioned by the Central Government to study the pharmaceutical sector. The report had highlighted several concerns regarding the functioning of the industry and had recommended measures, including nationalisation, to safeguard public health. However, these recommendations were not implemented by the government.

Another important issue raised in the petition was the continued availability in India of certain drugs that had already been banned in developed countries after scientific research established their harmful effects. It was argued that due to weak regulatory control and lack of proper enforcement, such drugs continued to be imported, manufactured, sold, and prescribed in India.

The petitioner also referred to the role of the Drugs Consultative Committee constituted under the Drugs and Cosmetics Act, 1940. The Committee had appointed a subcommittee to examine drugs and identify harmful ones. Although a list of injurious drugs had been prepared and recommended for banning, these drugs allegedly remained available in the Indian market.

The petitioner, therefore, sought directions from the Supreme Court to ensure effective control over the pharmaceutical sector, proper enforcement of drug safety laws, and removal of harmful drugs from circulation. The petition was based on Article 21 of the Constitution, asserting that the right to life includes the right to health and access to safe medical treatment.

Issues Before the Court

The Supreme Court in Vincent Panikurlangara v. Union of India considered the following issues:

• Whether the judiciary is the appropriate forum to decide on banning specific medicines, particularly when such decisions involve technical and scientific evaluation.
• Whether the government has a constitutional obligation to ensure public health and safety, including regulation of drugs and elimination of harmful medicines.

Arguments of the Petitioner

The petitioner argued that certain drugs, which had already been recognised as harmful in developed countries, posed a similar risk to human health in India. Despite this, these drugs continued to be freely available and widely used in India due to lack of awareness and ineffective regulation.

It was contended that the continued circulation of such drugs exposed citizens to serious health risks and demonstrated negligence on the part of the authorities responsible for ensuring drug safety.

The petitioner further submitted that the Drugs Consultative Committee had already examined these drugs and recommended their prohibition. However, no effective steps were taken to implement these recommendations, allowing harmful drugs to remain in the market.

On this basis, the petitioner requested the Court to issue directions to:

• Ban the import, manufacture, sale, and distribution of harmful and injurious drugs
• Cancel existing licences permitting such activities
• Ensure strict enforcement of the provisions of the Drugs and Cosmetics Act, 1940

The petitioner emphasised that judicial intervention was necessary in order to protect public health and enforce the fundamental right to life under Article 21.

Relevant Legal Provisions

The case involved interpretation of both statutory provisions and constitutional principles.

• Under the Drugs and Cosmetics Act, 1940, Sections 10-A and 26-A empower the Central Government to prohibit the import, manufacture, sale, and distribution of drugs in public interest. These provisions are intended to ensure that harmful or unsafe drugs do not reach the market.
• From a constitutional perspective, Article 21 guarantees the right to life and personal liberty. The Court has interpreted this right broadly to include various aspects necessary for a dignified life, including health and medical care.
• The Directive Principles of State Policy were also considered by the Court, particularly Articles 39, 41, 42, and 47. Article 47 imposes a duty on the State to improve public health and raise the standard of living. These principles, although not enforceable in a court of law, guide the interpretation of fundamental rights.

Analysis and Reasoning of the Court

The Supreme Court in Vincent Panikurlangara v. Union of India acknowledged the seriousness of the issues raised in the petition, especially the implications of harmful drugs being available in the market. However, the Court carefully examined the limits of judicial intervention in such matters.

The Court observed that decisions regarding banning specific drugs involve complex technical and scientific considerations. Such decisions require expert evaluation by specialised bodies with necessary knowledge and expertise. Therefore, the Court held that it would not be appropriate for the judiciary to directly decide which drugs should be banned.

At the same time, the Court emphasised that in a welfare state, the government has a primary responsibility to ensure the health and well-being of its citizens. It held that the State must create conditions conducive to good health, regulate the production and distribution of medicines, and eliminate harmful drugs from the market.

The Court further stated that the right to life under Article 21 includes the right to health. It observed that access to safe and effective medicines is an essential component of this right. Any failure to control harmful drugs may result in violation of Article 21.

In interpreting Article 21, the Court relied on the Directive Principles of State Policy. It held that fundamental rights derive meaning from these principles, particularly Articles 39, 41, 42, and 47. Article 47, which requires the State to improve public health, was given special importance.

The Court observed that maintenance and improvement of public health is essential for the physical existence of the community. Therefore, the State has a duty to take necessary measures to ensure that citizens are not exposed to harmful substances.

The Court also highlighted the importance of effective enforcement of laws. It stated that statutory provisions must be supported by proper implementation and, if necessary, penal consequences to ensure compliance. Mere existence of laws without enforcement would not achieve the intended objective.

Another important aspect considered by the Court was the role of statutory authorities. Referring to Article 144 of the Constitution, the Court held that all authorities, including statutory bodies, are required to act in aid of the Supreme Court. Therefore, both Central and State authorities have a duty to cooperate in matters affecting public interest.

The Court also addressed the issue of policy-making. It recognised that decisions such as banning specific drugs or nationalising the pharmaceutical industry fall within the domain of the executive. The judiciary should not interfere in such matters unless there is a clear violation of constitutional rights.

Thus, the Court adopted a balanced approach. It recognised the importance of protecting public health while respecting the principle of separation of powers.

Vincent Panikurlangara v. Union of India Judgment

The Supreme Court in Vincent Panikurlangara v. Union of India did not issue specific directions to ban particular drugs, holding that such decisions require expert evaluation and fall within the domain of the executive.

However, the Court made several important observations:

• The State has a constitutional obligation to ensure public health and regulate the pharmaceutical sector
• The right to life under Article 21 includes the right to health and access to safe medicines
• Directive Principles, especially Article 47, play a crucial role in interpreting fundamental rights
• The government must take effective steps to eliminate harmful drugs and ensure proper enforcement of drug laws
• Laws regulating drugs must be backed by adequate enforcement mechanisms, including penalties

The Court also emphasised the need for the government to formulate and implement an appropriate drug policy based on expert recommendations.

Conclusion

Vincent Panikurlangara v. Union of India remains a landmark judgment that highlights the importance of public health and the role of the State in ensuring safe medical practices. The decision makes it clear that the right to life includes the right to health and access to safe medicines.

While the Court refrained from directly intervening in policy decisions such as banning specific drugs or restructuring the pharmaceutical industry, it clearly articulated the constitutional obligations of the State. The judgment reflects a careful balance between protecting public interest and respecting the separation of powers.